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ANNUAL REPORT 2002
CONSOLIDATED FINANCIAL STATEMENTS
L’Oréal Annual Report 2002
The L’Oréal Annual Report 2002 comprises three separate documents: 
• a general brochure;
• the consolidated financial statements;
• the Management Report of the Board of Directors, 
together with the parent company financial statements 
and additional information for the Reference Document.
At its meeting on 25th March 2003, the Board of Directors closed the consolidated financial statements as presented below.
These financial statements will be submitted to the shareholders for approval at the Annual General Meeting on 22nd May 2003,
in accordance with article L. 225-100 of the French Commercial Code. The results were reviewed by the Board of Directors
on 19th February 2003 and announced in a news release on 20th February 2003.
The Board of Directors
Consolidated
financial statements 2002
(This is a free translation of the original French text for information purposes only.)
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CONSOLIDATED BALANCE SHEETS 
€ millions
31.12.2002 31.12.2001 31.12.2000
Assets (net values) Restated (1) Published
Fixed assets 8,130.4 8,140.3 7,605.1 7,605.1
Unissued share capital 0.1 0.1 0.1
Goodwill (note 4) 778.3 686.5 506.5 506.5
Intangible assets (note 5) 4,011.4 4,127.3 4,134.6 4,134.6
Tangible assets (note 6) 1,747.1 1,761.3 1,611.6 1,611.6
Financial assets 154.9 172.2 230.4 230.4
Investments in non-consolidated
companies (note 7) 4.8 12.9 75.0 75.0
Long-term loans and other debtors 69.7 78.8 79.3 79.3
Deposits and bonds 80.4 80.5 76.1 76.1
Investments in associated
companies (note 8) 1,438.7 1,392.9 1,121.9 1,121.9
Current assets 6,842.3 6,723.5 6,255.8 6,013.4
Stocks (note 9) 1,146.1 1,177.4 1,226.9 1,226.9
Prepayments to suppliers 63.9 68.9 79.3 79.3
Trade debtors (note 10) 1,991.5 2,191.8 2,168.4 2,168.4
Other debtors
and prepaid expenses (note 11) 1,424.7 1,331.2 1,193.7 951.3
Short-term investments (note 12) 1,671.7 1,409.3 1,081.7 1,081.7
Cash and other short-term funds 544.4 544.9 505.8 505.8
Unrealised translation losses 8.4 16.0 16.0
TOTAL ASSETS 14,972.7 14,872.2 13,876.9 13,634.5
(1) The 2000 data presented as Restated allow for the impact of introducing the preferential method for the booking of employee retirement obligation and related
benefits on the balance-sheet (see note on "Changes in accounting principles").
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€ millions
31.12.2002 31.12.2001 31.12.2000
Liabilities Restated (1) Published
Shareholders’ equity
(after minority interests) (note 13) 7,421.8 7,199.1 6,168.6 6,590.4
Share capital 135.2 135.2 135.2 135.2
Share premium account 953.4 953.4 953.4 953.4
Reserves 5,055.8 4,819.8 4,110.6 4,532.4
Net book profit 1,277.4 1,290.7 969.4 969.4
Minority interests (note 14) 11.9 10.7 9.9 9.9
Provisions for liabilities
and charges (note 15) 1,512.7 1,546.5 1,468.6 722.3
Loans and debts (note 16) 2,646.1 2,938.9 3,423.6 3,423.6
Current liabilities 3,380.2 3,170.4 2,799.9 2,882.0
Accruals and deferred income 0.7 2.4 2.2 2.2
Trade creditors 2,006.7 1,847.1 1,726.9 1,726.9
Other creditors 1,372.8 1,320.9 1,070.8 1,152.9
Unrealised translation gains 6.6 6.3 6.3
TOTAL LIABILITIES 14,972.7 14,872.2 13,876.9 13,634.5
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€ millions
CONSOLIDATED 
PROFIT AND LOSS ACCOUNTS
31.12.2002 31.12.2001 31.12.2000 (1)
Net sales (note 19) 14,288.0 13,740.4 12,671.2
Purchases 
and variation in stocks -2,519.0 -2,566.4 -2,352.3
Personnel costs (note 20) -2,757.0 -2,624.3 -2,361.4
External charges -6,521.2 -6,279.3 -5,807.7
Taxes other than on income -211.6 -182.7 -160.4
Depreciation -449.7 -431.8 -385.5
Charges to provisions (note 22) -51.2 -29.9 -63.1
Operating profit 1,778.3 1,626.0 1,540.8
Exchange gains and losses 62.3 43.0 -59.5
Adjusted operating profit 1,840.6 1,669.0 1,481.3
Financial expense - net (note 23) -142.2 -167.3 -159.3
Pre-tax profit of fully 
consolidated companies 1,698.4 1,501.7 1,322.0
Income tax (note 24) -579.8 -535.9 -488.5
Net profit before capital gains
and losses and minority interests
of fully consolidated companies 1,118.6 965.8 833.5
Group’s share of net profit before capital 
gains and losses and minority interests
of equity affiliates (note 25) 345.2 269.8 199.9
Net profit before capital gains
and losses and minority interests 1,463.8 1,235.6 1,033.4
Charges to provisions for depreciation
of treasury shares - net -80.3 — —
Capital gains and losses
on disposals of fixed assets - net (note 26) -16.6 130.7 -10.3
Restructuring costs - net (note 27) -31.5 -28.3 -24.3
Amortisation of goodwill (note 28) -50.3 -40.7 -24.0
Net book profit
before minority interests 1,285.1 1,297.3 974.8
Minority interests -7.7 -6.6 -5.4
Net book profit 
after minority interests 1,277.4 1,290.7 969.4
Average number of shares outstanding 675,990,516 676,062,160 676,062,160
Net book profit after minority 
interests per share (in euros) 1.89 1.91 1.43
Net profit before capital gains and
losses and after minority interests 1,456.2 1,229.1 1,027.8
E.P.S.: Net profit before capital gains
and losses and after minority
interests per share 2.15 1.82 1.52
(in euros) (note 29)
(1) The 2000 figures have been restated to bring them into compliance with the group’s Accounting Plan in 2001. 
The restatements do not affect any of the profit figures published in 2000.
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CHANGES IN CONSOLIDATED
SHAREHOLDERS’ EQUITY
€ millions
Number of shares Share Premiums Translation Consolidated Changes in L’Oréal Total
outstanding capital adjustments(1) reserves accounting shares held by
and profit methods consolidated
companies
At 31.12.1999
new reference 676,062,160 135.2 953.4 -308.4 4,845.5 171.9(2) 5,797.6
Recording of employee
retirement obligation -338.5(3) -338.5
At 31.12.1999 
restated 676,062,160 135.2 953.4 -308.4 4,845.5 -166.6 5,459.1
Recording of employee
retirement obligation -83.3(4) -83.3
Dividends paid 
(not paid on treasury shares) -236.9 -236.9
Translation adjustment 57.6 57.6
Other movements(5) 2.7 2.7
2000 consolidated
net profit 969.4 969.4
(after minority interests)
At 31.12.2000 
restated 676,062,160 135.2 953.4 -250.8 5,580.7 -249.9 6,168.6
Dividends paid 
(not paid on treasury shares) -317.6 -317.6
Translation adjustment 21.9 21.9
Other movements(5) 35.5 35.5
2001 consolidated
net profit 1,290.7 1,290.7
(after minority interests)
At 31.12.2001 676,062,160 135.2 953.4 -228.9 6,589.3 -249.9 7,199.1
Dividends paid 
(not paid on treasury shares) -391.7 -391.7
Translation adjustment -565.6 -565.6
Change in number of
L’Oréal shares held
by consolidated companies -1,640,000 -116.1 -116.1
Other movements(5) 18.7 18.7
2002 consolidated
net profit 1,277.4 1,277.4
(after minority interests)
At 31.12.2002 674,422,160 135.2 953.4 -794.5 7,493.7 -249.9 -116.1 7,421.8
(1) The figure of -€ 794.5 million at 31st December 2002 includes -€ 63.5 million of translation adjustment for subsidiaries situated in the euro zone.
(2) This amount reflects the application of Regulation 99-02, and in particular the booking of deferred tax according to the extended concept, and the activation of
financial lease contracts whose impact is material.
(3) This reflects the impact of adopting the preferential method for provisions relating to employee retirement obligation and related benefits
(see chapter on "Accounting principles and comparability of financial statements").
(4) The adjustment of some economic hypotheses and the introduction of new systems in 2000 have an impact of € 83.3 million for the year considered.
(5) The other movements figure relates mainly to Sanofi-Synthélabo.
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CONSOLIDATED 
CASH FLOW STATEMENTS
€ millions
31.12.2002 31.12.2001 31.12.2000 (1)
Cash flow from operating activities
Profit of fully consolidated companies 939.9 986.6 769.4
Elimination of expenses 
and income with no impact 
on cash flow:
• depreciation and provisions 721.2 556.4 507.5
• variation in deferred taxes -94.9 -19.5 -4.6
• losses or gains on disposals 
of assets of fully consolidated companies 15.4 -104.2 15.8
• other non-cash movements -2.5 -1.5 -1.9
Cash flow
of fully consolidated companies 1,579.1 1,417.7 1,286.2
• dividends received from equity affiliates 94.4 62.9 49.1
• variation in working capital requirement (note 30) 162.8 139.2 -356.6
Net cash provided
by operating activities (A) 1,836.3 1,619.9 978.7
Cash flows from investing activities
• acquisitions of fixed assets -539.1 -564.7 -480.3
• variation in other financial assets (note 31) -476.3 -323.0 -465.5
• disposals of fixed assets 26.8 -16.7 15.9
• effect of changes in the scope 
of consolidation (note 32) -202.6 151.6 -1,194.9
Net cash used
by investing activities (B) -1,191.2 -752.8 -2,124.8
Cash flows from financing activities
• dividends paid -427.0 -345.4 -266.7
• variation in loans -242.2 -393.7 1,368.7
Net cash used by financing activities (C) -669.2 -739.1 1,102.0
Effect of exchange rate fluctuations (D) -40.7 -3.3 3.3
Change in cash and cash equivalents
(A+B+C+D) -64.8 124.7 -40.8
Cash and cash equivalents 
at beginning of year (E) 594.1 469.4 510.2
Cash and cash equivalents 
at end of year (A+B+C+D+E) (note 33) 529.3 594.1 469.4
(1) The 2000 figures have been restated to bring them into compliance with the group’s Accounting Plan in 2001. The restatements affected the cash flow of the fully
consolidated companies and the variation in working capital requirement by € 9.1 million in 2000. Overdrafts have been reclassified as cash and cash equivalents
instead of debts.
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NOTE 1 - ACCOUNTING PRINCIPLES
The financial statements are presented in millions of euros.
The consolidated financial statements of L’Oréal and its sub-
sidiaries ("the group") have been prepared since 1st January
2000 in accordance with "the new accounting rules and
methods for the consolidated financial statements", appro-
ved by the order of 22nd June 1999 homologating Regulation
CRC 99-02.
a) Changes in accounting principles 
and comparability of financial statements
1) 2002
Since 1st January 2002, the L’Oréal group has been applying
Regulation CRC 00.06 on liabilities. The application of this
regulation has had no material effect on shareholders’ equity at
the beginning of the year.
Since 1st January 2002, the group has also chosen to adopt
the preferential method stipulated in Regulation CRC 99-02
concerning the recording in the financial statements of
unrealised translation gains and losses. The adoption of
the preferential method has no material impact on the
results of the accounting periods presented, or on share-
holders’ equity at the beginning of the year.
2) 2001
From 1st January 2001 onwards, the group has opted for the
preferential method stipulated in Regulation CRC 99-02
concerning the recording on the balance sheet of all employee
retirement obligation and related benefits. Previously, the net
liabilities of the capitalised funds were recorded as provisions
for charges or debts, or as off-balance sheet liabilities. 
The figures indicated for 2000 in the balance sheet under the
heading "Restated" allow for the impact of this change in the
accounting principle; the impact on the financial statements
of the years presented is not material.
This change has resulted in:  
• an increase in provisions for liabilities and charges of 
€ 664.2 million for year ending 31st December 2000,
• an increase in deferred tax assets of € 242.4 million for
year ending 31st December 2000,
• a reduction in shareholders’ equity of € 421.8 million for
year ending 31st December 2000.
Furthermore, the reclassification on the balance sheet of
debts arising from liabilities relating to employee retire-
ment obligation and related benefits under the heading
Provisions for liabilities and charges amounts to € 82.1
million for year ending 31st December 2000.
3) 2000
It should be noted that the application of Regulation CRC 99-02
with effect from 1st January 2000, has resulted in the following
changes: 
• The inclusion of deferred tax liabilities evaluated using the
balance sheet approach and the extended concept. The
impact of these liabilities for the periods considered has
not been significant but led to an increase in shareholders’
equity of € 166.8 million on 1st January 2000.
• The adoption of the preferential method for the capital-
isation, in the financial statements for year ending 
31st December 2000, of substantial capital lease contracts
(financial leasing). This change in accounting principles had
a positive net impact of € 5.1 million on shareholders'
equity at the beginning of 2000. The impact on the results
of the accounting periods presented is not material.
• The introduction of new accounting principles relating to
the acquisition of shares in consolidated companies. It is
hereby indicated that, in accordance with the derogation
granted in Regulation CRC 99-02, the group has opted for
a forward-looking application of transactions relating to
acquisitions and disposals of the shares of consolidated
companies.
In the profit and loss account, reclassifications have been
carried out on the figures for 2000 to bring them into 
compliance with the stipulations of the group’s Accounting
Plan. These reclassifications have no impact on the levels of
results presented.
The acquisitions and disposals of shares carried out in 2000
and 2001 have no significant impact on the structure of 
the financial statements presented.
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b) Scope and method of consolidation
All companies included in the scope of consolidation have a 
fiscal year ending 31st December or carry a cut-off on that date.
All companies directly or indirectly controlled by the parent
company, L’Oréal, have been consolidated by the full conso-
lidation method, redeeming minority shareholders’ interests
via the partial revaluation method.
Group companies that are jointly controlled by the parent
company and a limited number of other shareholders under
a contractual agreement have been consolidated by the 
proportional consolidation method.
Associated companies of a significant size in which the
group holds a substantial interest have been accounted for
by the equity method.
c) Foreign currency translation
1) Accounting for foreign currency transactions 
in consolidated companies
Foreign currency transactions are based on the exchange
rates of the transaction date. Exchange gains or losses 
arising from the movement in exchange rates between 
the date of the transaction and the related payment or
receipt are recorded in the profit and loss account, net of
related hedging instruments.
Debtor and creditor balances denominated in foreign 
currencies have been translated using exchange rates as at
the fiscal year end. Unrealised translation gains and losses are
entered on the financial statements, as are the revaluations of
the related hedging instruments.
The group may decide to cover certain investments in foreign
companies by contracting debts in the same currency.
Exchange gains or losses relating to these debts are charged
to consolidated shareholders’ equity.
2) Translation of the accounts of foreign subsidiaries
The assets and liabilities of foreign subsidiaries are translated
at the exchange rates ruling at the fiscal year end. Profit and
loss accounts are translated at average exchange rates for
the year.
Variations in translations are recorded as follows:
• differences relating to the group’s share are recorded 
in shareholders’ equity under Translation adjustment,
• differences relating to minorities are recorded under
Minority interests.
d) Goodwill
Goodwill consists of the difference between the cost of the
acquisition of the shares and the fair value of the assets and
liabilities identified, after allowing for any deferred tax liabili-
ties at the date of acquisition.
Further complementary acquisitions of shares do not result
in any modification of the valuations of the assets and 
liabilities identified, as determined at the date the controlling
interest already consolidated is taken.
Goodwill is amortised by the straight-line method over a
maximum period of twenty years, taking into account the
objectives set and the forecasts made at the time of the
acquisition. 
Exceptional amortisation is recorded if any unfavourable
changes occur in the items used as the basis for the amorti-
sation plan.
e) Intangible assets
Intangible assets are recorded on the balance sheet at cost
price. Those items identified following an acquisition are also
included in this item. They consist mainly of trademarks, market
share and business value, which are recorded on the balance
sheet using the partial revaluation method.
The value of the newly-acquired brands is calculated based
on various factors including their reputation and potential
contribution to profits. 
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When the group acquires assets and shares of consolidated
companies, the proportion of the acquisition price that rela-
tes to the obtaining or strengthening of the group’s position
in certain markets is entered under the item Market share.
Market shares are valued on the date of acquisition by 
reference to economic data relating to sales and profitability
indicators.  
The Business value item consists of business value acquired
and allocations of some fair value adjustments made prior to
1st January 2000.
The depreciation periods of intangible assets are as follows:
Start-up costs 1 – 5 years
Trademarks, market shares and business value not amortised
Other intangible assets 2 – 8 years
The group ensures that the intangible assets recorded in the
consolidated balance sheet have a net book value below their
utility or market value. Brands and market shares are valued
annually by applying the same criteria used at the date of
acquisition. In the case of business value, the main criteria
considered are trends in sales volume and profitability. 
If a durable reduction in these values occurs, a depreciation is
recorded.
f) Tangible assets  
Tangible assets are recorded on the balance sheet on the
basis of their acquisition price. Tangible assets identified 
following an acquisition are recorded on the balance sheet
using the partial revaluation method.
The depreciation periods of tangible assets are as follows:
Buildings 20 – 50 years
Industrial machinery and materials 5 – 10 years
Other tangible assets 3 – 10 years
The straight-line and declining balance methods used are
considered to represent economic depreciation.
Key capital goods financed through capital leases are record-
ed as assets on the balance sheet under Tangible assets and
are amortised by the straight-line method using the 
periods indicated above. The corresponding debt is recorded
under liabilities.  
g) Investments in non-consolidated companies
Investments in non-consolidated companies are stated 
at their acquisition cost value. Provision is made for any
reduction in fair value, determined on the basis of the finan-
cial criteria most appropriate to the specific situation of each
company. The criteria usually adopted are: the group’s share
of net assets, profitability and share price.
h) Stocks
Stocks are valued using the weighted average cost or the
"first in, first out" method.
Provision is made for obsolete and slow-moving stocks on
the basis of actual and forecast sales.
i) Trade debtors
Trade debtors are recorded at their nominal value.
Provision is made for any uncertain debts based on an
assessment of the risk of non-recovery.
j) Prepayments and accrued income
This item consists both of charges recorded in this account-
ing period but which relate to subsequent accounting 
periods, and of charges recorded in this accounting period
but which may be deferred to several subsequent accounting
periods.
The item includes point of sales advertising material and
sales counters, whose costs may be spread over a maximum
period of use of 5 years.
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k) Short-term investments
These investments are stated at cost. Provision is made where
the year-end market value is below the acquisition cost. 
l) Treasury shares - Share option schemes - 
Share buyback programme
Treasury shares retained by the group which are specifically
allocated to employee share option schemes are entered
under Short-term investments.
Stock options are intended to involve, motivate and 
strengthen the loyalty of employees who make the largest
contribution to the group’s performance through their skills
and commitment. 
In the case of share option schemes prior to 2000, a provision
for depreciation has been made to cover the difference 
between the acquisition price of the shares and the price at
which the options are exercised by the beneficiaries. Since 
1st January 2000, no discount has been granted on the option
allocation price. Provided that the shares are purchased at 
a lower price than the attribution price, no provision for depre-
ciation is required. However, a provision is made in the event
of any decline in the share price; the provision consists of the
difference between the net book value of the shares and the
average share price over the month preceding the balance-
sheet date.
Share options do not cause any dilution of equity by the 
creation of shares. They have no impact either on the amount
or the structure of the equity.
In accordance with Article L. 225-102 of the French Commercial
Code, French employees of the group hold L’Oréal shares
through two unit trusts.
The acquisition cost of any treasury shares acquired as part of
the share buyback programme is deducted from consolidated
shareholders’ equity.
m) Provisions for liabilities and charges
Provisions for liabilities and charges are set up to cover
potential outlays for the benefit of third parties without a
return for the group. They relate mainly to tax liabilities and liti-
gation, industrial and commercial liabilities relating to opera-
tions (breach of contract, product returns) and personnel
costs.
They are estimated on the basis of the most likely hypotheses
or by using statistical methods, depending on the type of 
provisions. 
Provisions for employee retirement obligation and related
benefits, and deferred tax liabilities, are also recorded under
this heading.
n) Provisions for employee retirement 
obligation, early retirement 
and related benefits
The group has decided to declare in the consolidated 
financial statements all employee retirement obligation and
related benefits from 1st January 2001.
The group adheres to local legislation and regulations in its
management of pensions, early retirement and other related
benefit schemes.  
The characteristics of the schemes in force in the group are as
follows:
• French regulations provide for specific length-of-service
awards payable to employees on retirement. In addition, an
early retirement plan and a defined benefit plan have been
set up. In some group companies there are also measures
providing for the payment of certain healthcare costs for
retired employees.
These obligations, except for those relating to healthcare
costs for retired employees, are partially covered by external
financial plans.
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• For foreign subsidiaries with employee pension schemes
or other specific obligations relating to defined benefits,
the excess of obligations over the scheme’s assets is
recognised by setting up a provision for charges on the
basis of the actuarial value of the vested rights of
employees.
The charges recorded in the profit and loss account, under
the heading Personnel costs, include:
• additional rights acquired by employees during the
accounting period,
• the change in the value of the rights when they are updated
at the start of the accounting period based on the annual
trends,
• the income from external funds calculated on the basis of
the standard return on long-term investments,
• the impact of any changes to schemes in previous years or
of any new schemes,
• the depreciation of any variation from the actuarial calcul-
ation.
The debt relating to the company’s net personnel obligation
is recorded as a liability on the balance sheet, under the 
heading Provisions for liabilities and charges.
To determine the discounted value of the obligation for each
scheme, the group uses an actuarial allocation method on 
a final salary basis (projected credit unit method). The obli-
gations and the coverage assets are valued each year, 
allowing for length of service, life expectancy, staff turnover
by category and economic hypotheses (inflation rate and 
discounting rate).
The cumulative effects of variations from the actuarial 
calculations are depreciated over the average residual period
of activity of active employees, unless such variations do not
exceed 10% of the higher of the gross commitment amount
or the fair value of the covering assets (corridor principle).
The depreciation of the difference is included in the annual
actuarial charge of the following accounting period.
Differences observed in relation to other benefits, such as
jubilees and medals, are immediately charged to the profit
and loss account without the application of the corridor 
principle.
o) Net sales
Consolidated sales include sales of products, goods and raw
materials, as well as other revenues and service income 
related to the group’s normal activities.
They are stated net of rebates and discounts.
p) Advertising and public relations expenses
Expenses relating to the advertisement and promotion of
products to customers and consumers are charged to the
profit and loss account of the accounting period during
which they are incurred. An exception to this is the cost of
samples and point of sales materials that are still considered
to be commercially useful and that are recorded on the
balance sheet under Prepayments and accrued income.
q) Research and development expenditure
Research and development expenditure is charged to the
profit and loss account of the fiscal year during which it is
incurred.
r) Adjusted operating profit
Adjusted operating profit includes exchange gains and 
losses, employee profit sharing, and exceptional expenses
and income generated by the group’s operations.
s) Income tax
This is the sum of the income tax payable by each consolid-
ated fiscal entity, after adjustment to allow for deferred tax. 
Deferred tax is calculated wherever temporary differences
occur between the tax base and the consolidated statement
of assets and liabilities, using a balance sheet approach and
variable carry-forward. Deferred tax includes irrecoverable
taxation on estimated or confirmed dividends. 
Deferred tax is calculated on the basis of the rate of taxation
and the fiscal rules in force at the balance sheet date, which
will also be in force once the temporary differences no longer
apply.
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Deferred tax assets are only recorded in the case of tax loss
carry-forwards from consolidated entities if it is probable that
the entities will be able to recover them through taxable pro-
fits from the period in which the deferred tax assets are valid.
Under the French system of fiscal consolidation, some
French companies in the group compensate for their taxable
incomes when determining the overall tax charge which only
the parent company L’Oréal remains liable to pay. Fiscal
consolidation systems also exist outside France.
t) Net profit before capital gains and losses
and minority interests
This item consists of the net book profit before the following:
• charges to/reversals of provisions for depreciation of treasury
shares net of tax,
• capital gains or losses, net of tax, on the disposal of fixed
assets,
• restructuring costs net of tax,  
• amortisation of goodwill.
u) Method used to calculate earnings 
per share 
Earnings per share is obtained by dividing net profit before
capital gains and losses and after minority interests by the
number of shares outstanding during the accounting period,
after deducting the average number of shares held by
consolidated companies and thus deducted from sharehol-
ders’ equity.
Treasury shares allocated to employees under existing share
option schemes are carried under Short-term investments.
They are therefore included in the number of shares out-
standing.
v) Recording of financial instruments 
and derivatives
In accordance with group financial management policies,
none of L’Oréal’s consolidated companies conduct any
money market transactions for speculative reasons:
• With regard to exchange rates, long-term contracts and
options are negotiated to cover commercial transactions
recorded on the balance sheet and cash flows on com-
mercial transactions whose completion is considered to be
highly probable. The losses and gains generated by these
instruments are recorded symmetrically with the items that
they cover.
• With regard to the instruments used to hedge cash flows
relating to commercial transactions for the next fiscal year,
estimated on the basis of information provided by the sub-
sidiaries, the non-realised exchange losses and gains are
deferred until the date of completion of the transactions
covered.
• With regard to the interest rate risk, the profits generated
by interest rate swaps covering financial liabilities are
recorded symmetrically with the profit on the debts cover-
ed, prorata temporis.
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NOTE 2 - CHANGES IN THE SCOPE OF CONSOLIDATION 
a) Acquisitions
The acquisitions made during the 2002 fiscal year are as follows:
% acquired Entry date 2002 sales
since acquisition 
(€ millions)
Fully consolidated companies
Shu Uemura Cosmetic Corporate (Taiwan) 75.00 January 2002 21.5
Proportionally consolidated companies
The Laboratoires Inneov(1) 50.00 August 2002 NA
Asset acquisition
Artec(2) August 2002 13.3
(1) On 25th June 2002, the L’Oéal and Nestlé groups announced the signing of an agreement for the creation of a joint venture, The Laboratoires Innéov, whose aim
is to develop the market for cosmetic nutritional supplements worldwide. The Laboratoires Innéov has been proportionally consolidated since August 2002.
(2) At the end of August 2002, L’Oréal acquired Artec Systems Group Inc., a company which markets professional haircare and colourant products in American hair
salons.
The total price paid for the new acquisitions amounted to € 152 million.
Detailed figures on the goodwill resulting from these transactions are provided in note 4 Goodwill.
Shu Uemura Japan, a company in which the group acquired a 35% stake at the end of 2000 through its subsidiary Nihon
L’Oréal, has been consolidated by the proportional method since 1st January 2002. At 31st December 2001, this company was
accounted for by the equity method. At 31st December 2000, the recently acquired shares were entered under the Investments
in non-consolidated companies item (note 7).
The acquisitions made during the 2001 fiscal year were as follows:
% acquired Entry date 2001 sales
since acquisition
(€ millions)
Fully consolidated companies
Exclusive Signatures International (UK) 100.00 January 2001
Thai Shu Uemura (Thailand) 68.15 January 2001 10.7
Exclusive Signatures International(1) 100.00 January 2001
Cosbra (Brazil)(2) 100.00 July 2001 29.7
Equity consolidated companies
Shu Uemura Cosmetics (Japan) 35.00 January 2001 -
Nobara Inc (USA) 35.00 January 2001 -
Shu Uemura (Hong-Kong) 22.75 January 2001 -
Asset acquisition
Biomedic July 2001 5.1
(1) Company created by the group to manage the business of Shu Uemura internationally.
(2) Colorama brand.
The total price paid for these acquisitions amounted to € 212 million.
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b) Divestments
The group carried out no divestments in 2002.
In 2001, the group carried out the following divestments:
• In March, all stakes in the Marie Claire group were sold to Holding Evelyne Prouvost, controlled by Madame Evelyne Prouvost
and her family.
• In July, the totality of Lanvin S.A. and its worldwide subsidiaries were sold to a group of investors from the holding company
Harmonie S.A.
NOTE 3 - SECTORIAL INFORMATION
a) Consolidated sales
1) Breakdown of consolidated sales by branch
2002 Growth (as %) 2001 2000
€ millions % Published Excluding € millions % € millions %
of total figures exchange of total of total
effect
Cosmetics 13,951.8 97.6 4.2 8.9 13,394.2 97.5 12,317.4 97.2
Dermatology(1) 321.1 2.3 9.9 17.8 292.2 2.1 262.6 2.1
Other 15.1 0.1 - - 54.0 0.4 91.2 0.7
Group 14,288.0 100.0 4.0 8.8 13,740.4 100.0 12,671.2 100.0
(1) Group share, i.e. 50%.
2) Breakdown of consolidated sales by geographic zone
2002 Growth (as %) 2001 2000
€ millions % Published Excluding € millions % € millions %
of total figures exchange of total of total
effect
Western Europe 7,044.6 49.3 5.7 5.6 6,667.2 48.5 6,328.0 49.9
North America 4,438.7 31.1 -0.3 6.1 4,450.5 32.4 3,903.5 30.8
Rest of the World 2,804.7 19.6 6.9 22.7 2,622.7 19.1 2,439.7 19.3
Group 14,288.0 100.0 4.0 8.8 13,740.4 100.0 12,671.2 100.0
3) Breakdown of cosmetics sales by geographic zone
2002 Growth (as %) 2001 2000
€ millions % Published Excluding € millions % € millions %
of total figures exchange of total of total
effect
Western Europe 6,962.8 49.9 5.8 5.8 6,580.6 49.1 6,233.6 50.6
North America 4,224.8 30.3 -0.8 5.6 4,256.9 31.8 3,733.6 30.3
Rest of the World 2,764.2 19.8 8.1 24.0 2,556.7 19.1 2,350.2 19.1
Cosmetics branch 13,951.8 100.0 4.2 8.9 13,394.2 100.0 12,317.4 100.0
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b) Adjusted operating profit
1) Breakdown of adjusted operating profit by branch
€ millions 2002 2001 2000
Cosmetics 1,767.8 1,604.2 1,426.3
Dermatology 65.2 61.8 57.3
Other 7.6 3.0 -2.3
Group 1,840.6 1,669.0 1,481.3
2) Breakdown of cosmetics adjusted operating profit by geographic zone
€ millions 2002 2001 2000
Western Europe 970.9 874.8 850.4
North America 535.4 522.1 442.5
Rest of the World 261.5 207.3 133.4
Cosmetics branch 1,767.8 1,604.2 1,426.3
c) Fixed assets
1) Breakdown of net fixed assets by branch
€ millions Goodwill Intangible Tangible Financial 31.12.2002 31.12.2001 31.12.2000
assets assets and other
Net value fixed assets
Cosmetics 778.3 3,727.6 1,691.0 92.0 6,288.9 6,359.5 6,121.1
Dermatology 283.3 39.4 2.0 324.7 307.5 248.1
Other 0.5 16.7 60.9 78.1 80.3 113.9
Group 778.3 4,011.4 1,747.1 154.9 6,691.7 6,747.3 6,483.1
2) Breakdown of cosmetics net fixed assets by geographic zone
€ millions Goodwill Intangible Tangible Financial 31.12.2002 31.12.2001 31.12.2000
assets assets and other
Net value fixed assets
Western Europe 334.9 2,357.4 923.5 20.2 3,636.0 3,426.0 3,260.1
North America 346.8 1,290.2 529.8 50.9 2,217.7 2,417.9 2,398.8
Rest of the World 96.6 80.0 237.7 20.9 435.2 515.6 462.2
Cosmetics branch 778.3 3,727.6 1,691.0 92.0 6,288.9 6,359.5 6,121.1
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NOTE 4 - GOODWILL
€ millions 31.12.2001 Acquisitions Other 31.12.2002
Charges movements(1)
Artec 55.8 -11.9 43.9
Biomedic 8.7 0.9 2.6 12.2
Colorama 21.3 0.9 -9.5 12.7
Jade 18.6 18.6
Kiehl’s 15.7 -2.0 13.7
Laboratoires Ylang 18.1 -10.9 7.2
Matrix 274.3 -20.3 254.0
Maybelline International 65.9 -8.6 57.3
Nihon L’Oréal 84.0 2.9 -0.1 86.8
Sanofi Synthélabo (equity method) 28.9 162.1 191.0
Shu Uemura 50.3 3.6 3.9 57.8
Softsheen.Carson.Dermablend 182.6 -20.9 161.7
Other companies 24.6 0.4 -0.4 24.6
Gross value 793.0 226.6 -78.1 941.5
Artec 1.0 -0.1 0.9
Biomedic 0.1 0.9 1.0
Colorama 0.5 1.0 -0.5 1.0
Jade 5.8 0.9 6.7
Kiehl’s 1.1 0.8 -0.2 1.7
Laboratoires Ylang 1.7 8.0 -2.5 7.2
Matrix 19.5 14.4 -3.7 30.2
Maybelline International 20.0 1.5 18.6 40.1
Nihon L’Oréal 11.1 3.9 15.0
Sanofi Synthélabo (equity method) 3.6 3.0 6.6
Shu Uemura 2.4 4.1 -0.6 5.9
Softsheen.Carson.Dermablend 28.4 8.5 -4.8 32.1
Other companies 12.3 2.3 0.2 14.8
Amortisation 106.5 50.3 6.4 163.2
Net goodwill 686.5 176.3 -84.5 778.3
(1) This item consists mainly of changes in exchange rates affecting goodwill from foreign subsidiaries, and valuation adjustments during the allocation period.
Goodwill is amortised over a maximum period of twenty years. The goodwill amount takes account of deferred tax liabilities on trademarks and other
identifiable assets that could be sold separately from the company acquired.
Goodwill valuations may be provisional up to the end of the accounting period following the acquisition date.
All the goodwill relating to the earlier acquisition of Miss Ylang in Argentina was amortised in 2002 (€ 8 million) in view of the country’s economic situation.
The increase in the stake in the Sanofi-Synthélabo group has generated goodwill of € 162.1 million at 31st December 2002 (see note 8).
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NOTE 5 - INTANGIBLE ASSETS 
€ millions 31.12.2001 Acquisitions Disposals Translation Other 31.12.2002
Provisions Takeovers differences movements(1)
Licences, patents, trademarks
and market shares 1,106.5 125.3 -3.4 -121.7 29.8 1,136.5
Business value 3,044.9 -5.0 -139.6 0.1 2,900.4
Other intangible assets 113.5 27.1 -8.3 -6.7 11.6 137.2
Gross value 4,264.9 152.4 -16.7 -268.0 41.5 4,174.1
Licences, patents, trademarks
and market shares 70.9 11.7 -3.2 -4.2 -0.1 75.1
Business value 12.3 0.6 -0.4 0.1 -0.1 12.5
Other intangible assets 54.4 30.3 -7.2 -3.5 1.1 75.1
Amortisation 137.6 42.6 -10.8 -7.6 0.9 162.7
Intangible assets - net 4,127.3 109.8 -5.9 -260.4 40.6 4,011.4
(1) This consists mainly of the impact of variations in the scope of consolidation, of adjustments of the value of assets which are identifiable during the allocation
period and of the impact of the proportional consolidation at 1st January 2002 of the company Shu Uemura Japan in an amount of € 29.9 million under the
Trademarks item.
The impact of new inclusions in the scope of consolidation mainly relates to € 104.6 million under Market shares following the acquisition of Artec.
Valuations may be provisional up to the end of the accounting period following the acquisition date.
NOTE 6 - TANGIBLE ASSETS 
€ millions 31.12.2001 Acquisitions Disposals Translation Other 31.12.2002
Provisions Reversals differences movements(1)
Land and buildings 1,144.6 54.9 -31.9 -80.2 51.4 1,138.8
Machinery and equipment 1,766.4 163.2 -104.1 -152.7 54.7 1,727.5
Other tangible assets 
and work-in-progress 882.3 249.8 -63.3 -98.3 -116.7 853.8
Gross value 3,793.3 467.9 -199.3 -331.2 -10.6 3,720.1
Land and buildings 502.0 51.9 -19.1 -25.1 4.3 514.0
Machinery and equipment 1,064.0 137.6 -90.2 -86.8 -0.8 1,023.8
Other tangible assets
and work-in-progress 466.0 72.6 -55.7 -47.3 -0.4 435.2
Depreciation and provisions 2,032.0 262.1 -165.0 -159.2 3.1 1,973.0
Tangible assets - net 1,761.3 205.8 -34.3 -172.0 -13.7 1,747.1
(1) These are mainly the result of the impact of changes in the scope of consolidation, and fixed assets in progress allocated to the Other fixed assets items.
Tangible assets include capital lease contracts for the following amounts:
€ millions 31.12.2002 31.12.2001
Land and buildings 169.0 169.6
Machinery and equipment 7.2 7.2
Other tangible assets and work-in-progress 12.4 12.6
Gross value 188.6 189.4
Depreciation 77.3 67.7
Net value 111.3 121.7
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NOTE 7 - INVESTMENTS IN NON-CONSOLIDATED COMPANIES 
As at 31st December 2002, investments in non-consolidated companies amounted to € 12.3 million in gross value and
€ 4.8 million in net value compared with € 14.6 million and € 12.9 million respectively at 31st December 2001. As at
31st December 2000, investments in non-consolidated companies included € 61.3 million of shares following the acquisition
of a 35% interest in the Japanese company Shu Uemura (see note 2).
NOTE 8 - INVESTMENTS IN ASSOCIATED COMPANIES 
Investments in associated companies consist mainly of shares in the Sanofi-Synthélabo group, in which the L’Oréal group has
a 19.98% stake at 31st December 2002 compared with 19.54% at 31st December 2001. The increase in the percentage held
is the result of the buyback by Sanofi-Synthélabo of its own shares in 2002, which have been deducted from shareholders’
equity in its consolidated financial statements. This transaction generated goodwill of € 162.1 million in the financial state-
ments of L’Oréal at 31st December 2002 (see note 4).
At 31st December 2001, investments in associated companies included € 32 million relating to the stake in Shu Uemura Japan;
as indicated in the section on Changes in the scope of consolidation, this stake is now consolidated by the proportional
method (see note 2).
€ millions % interest Contribution at 31.12.2002 Balance-sheet value
Consolidated Consolidated
reserves profit for year 31.12.2002 31.12.2001
Sanofi-Synthélabo 19.98 1,092.6 344.9 1,437.5 1,360.0
Club des Créateurs de Beauté (Japan) 20.00 0.9 0.3 1.2 0.9
Shu Uemura Japan - - - - 32.0
Investments 
in associated companies 1,093.5 345.2 1,438.7 1,392.9
NOTE 9 - STOCKS
€ millions 31.12.2002 31.12.2001
Raw materials, packaging, consumables 397.8 396.9
Semi-finished and finished products 933.5 985.6
Gross value 1,331.3 1,382.5
Provisions for depreciation 185.2 205.1
Stocks - net 1,146.1 1,177.4
NOTE 10 - TRADE DEBTORS
€ millions 31.12.2002 31.12.2001
Trade debtors 2,075.7 2,273.2
Gross value 2,075.7 2,273.2
Provisions for depreciation 84.2 81.4
Net value 1,991.5 2,191.8
Trade debtors are due within one year.
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NOTE 11 - OTHER DEBTORS AND PREPAID EXPENSES
€ millions 31.12.2002 31.12.2001
Fiscal and social debtors 332.7 316.2
Other debtors 150.3 115.3
Charges to be apportioned 192.6 201.4
Prepaid expenses 160.6 152.7
Point of sales advertising 109.3 119.7
Deferred tax 479.2 425.9
Total 1,424.7 1,331.2
NOTE 12 - SHORT-TERM INVESTMENTS
€ millions 31.12.2002 31.12.2001
L’Oréal shares 1,653.5 1,280.8
Unit trusts, etc. 160.5 142.7
Gross value 1,814.0 1,423.5
Provisions for depreciation 142.3 14.2
Net value 1,671.7 1,409.3
The 24,984,050 L’Oréal shares held for the employee share option scheme have a net value of € 1,516.2 million (after allowing
for a charge of € 124.4 million under Provisions for depreciation in 2002) compared with € 1,267.2 million at 31st December 2001. 
During 2002, 5,000,000 shares were purchased and 652,850 share options were taken out.
The total stock market value based on the closing price at 31st December 2002 was € 1,812.6 million, compared with € 1,669.5 mil-
lion at 31st December 2001.
At 31st December 2002, the market value of the unit trusts was € 154.8 million, and their net value was € 141.6 million.
NOTE 13 - SHAREHOLDERS’ EQUITY (AFTER MINORITY INTERESTS)
The share capital consists of 676,062,160 shares with a par value of € 0.20.
A L’Oréal share buyback programme was authorised by the Annual General Meeting of Shareholders on 29th May 2002 in order
to contribute to an increase in the value of the assets of the group’s shareholders.
Under this programme, 1,640,000 shares were acquired on 31st December 2002 for an amount of € 116.1 million. The acqui-
sition cost of these shares has been deducted from consolidated shareholders’ equity.
NOTE 14 - MINORITY INTERESTS
Minority interests related only to a few companies in amounts that were not material. The amounts were € 11.9 million and
€ 10.7 million at 31st December 2002 and 2001 respectively.
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NOTE 15 - PROVISIONS FOR LIABILITIES AND CHARGES
a) Balances at balance-sheet date
€ millions 31.12.2002 31.12.2001
Provisions for employee retirement obligation and related benefits 896.3 893.0
Provisions for exchange losses - 3.5
Deferred tax liabilities 45.0 88.7
Other provisions for liabilities and charges(1) 512.1 480.8
Provisions for restructuring 59.3 80.5
Total 1,512.7 1,546.5
(1) This item includes provisions set aside for tax liabilities and litigation, industrial and commercial liabilities relating to operations (breach of contract, product
returns) and personnel costs.
b) Variations in Provisions for restructuring and Other provisions for liabilities and charges 
during year
€ millions 31.12.2001 Charges(2) Reversals Reversals Impact of 31.12.2002
(used)(2) (not used)(2) change in scope
of consolidation/
exchange rate/
others(1)
Other provisions
for liabilities and charges 480.8 207.3 -94.0 -29.7 -52.3 512.1
Provisions for restructuring 80.5 13.3 -23.2 -3.1 -8.2 59.3
(1) Mainly resulting from currency fluctuations.
(2) These figures may be analysed as follows:
€ millions Charges Reversals Reversals
(used) (not used)
• Restructuring costs 13.3 -23.2 -3.1
• Operating provisions 171.4 -92.9 -29.7
• Financial provisions 18.9 - -
• Income tax 17.0 -1.1 -
c) Provisions for employee retirement obligation and related benefits
Employee retirement obligation and related benefits comprise in particular:
• pensions and benefits linked to retirement and/or early retirement,
• social benefits for retired employees (pensions, retirement bonuses, life insurance, medical assistance, etc.),
• other long-term benefits (gifts and long service awards).
Provisions for pensions and early retirement benefits
Employee retirement commitments are calculated using an actuarial allocation method on a final-pay basis (projected credit
unit method). Since 1st January 2001, all obligations relating to pensions still to be paid to retired employees and the vested
rights of employees have been included in the calculation. With regard to length-of-service awards payable on retirement, the
calculation is made by straight-line depreciation over the whole length of active service of the employee in the group.
The actuarial assumptions used to calculate these commitments take into account the economic conditions in each country
or in each group company. The average weighted assumptions for the group are as follows:
31.12.2002 31.12.2001
• Discount rate 5.7 % 6.2 %
• Rate of salary increase 4.5 % 4.9 %
• Long-term return on assets 6.8 % 7.6 %
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Social and other long-term benefits after retirement
These benefits have been evaluated on the basis of the same actuarial assumptions as those used to calculate pensions. 
Provisions have been made for all obligations relating to retired employees and for the vested rights of employees.
The variations during 2002 and 2001 are set out below:
€ millions Actuarial liability Coverage assets Actuarial differences Balance-sheet
provisions
Balance at 1st January 2001 1,541.1 780.5 -96.5 857.1
Amounts for year:
Vested rights 80.0 - - 80.0
Impact of adjustment 92.6 92.6
Yield of funds - 56.7 -56.7
Depreciation of actuarial differences - -0.3 0.3
Benefits paid -61.3 -27.1 -34.2
Contributions paid 5.1 49.5 -44.4
Actuarial differences not entered on balance-sheet 28.6 -145.1 173.8 -0.1 
Exchange rate impact 12.7  19.0 -4.7 -1.6
Other movements - -
Balance at 31st December 2001 1,698.8 733.5 72.3 893.0
Amounts for year:
Vested rights 88.9 88.9
Impact of adjustment 93.5 93.5
Yield of funds 55.7 -55.7
Depreciation of actuarial differences -2.0 2.0
Benefits paid -68.8 -44.8 -24.0
Contributions paid 5.2 102.9 -97.7
Actuarial differences not entered on balance-sheet 42.2 -109.3 151.2 0.3
Exchange rate impact -82.5 -58.9 -18.9 -4.7
Other movements 4.2 0.3 3.2 0.7
Balance at 31st December 2002 1,781.5 679.4 205.8 896.3
The retirement obligation booked as charges may be analysed as follows: 
€ millions 31.12.2002 31.12.2001
Employees rights conferred during year 88.9 80.0
Adjusted vested rights obligation 93.5 92.6
Yield of funds -55.7 -56.7
Depreciation of actuarial differences 2.0 0.3
Total 128.7 116.2
NOTE 16 - LOANS AND DEBTS 
The group carries out financing through medium-term bank loans, and by the issue of short-term paper in France and the issue
of short-term commercial paper in the United States. The two programmes represent amounts of € 1,600 million and
USD 800 million respectively.
Liquidity for the issue of commercial paper is ensured by confirmed lines of bank cash. The cash lines, like the medium-term
loans, are not subject to any financial ratio clauses or rating clauses.
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Debt by type
€ millions 31.12.2002 31.12.2001
Short-term paper 1,296.9 1,440.7
Bank loans 1,032.4 1,235.6
Perpetual loan 53.6 61.8
Debts on capital lease contracts 91.0 103.4
Debenture loans 5.9 6.9
Overdrafts 166.3 90.5
Total 2,646.1 2,938.9
Debt by maturity date
€ millions 31.12.2002 31.12.2001
Under 1 year 1,821.1 2,063.6
1 to 5 years 706.1 721.1
Over 5 years 118.9 154.2
Total 2,646.1 2,938.9
Debt by currency
(after allowing for currency hedging instruments)
€ millions 31.12.2002 31.12.2001
Euro (EUR) 1,562.5 1,807.8
US dollar (USD) 805.6 627.0
Pound Sterling (GBP) 3.3 146.0
Yen (JPY) 39.9 96.5
Others 234.8 261.6
Total 2,646.1 2,938.9
Breakdown of fixed rate and floating rate debt  
(after allowing for interest rate hedging instruments)
€ millions 31.12.2002 31.12.2001
Floating rate 1,810.6 2,092.3
Fixed rate 835.5 846.6
Total 2,646.1 2,938.9
Average debt interest rates
The average debt interest rates, after allowing for hedging instruments, were 4.6% in 2001 and 3.6% in 2002 for the euro,
and 5.1% in 2001 and 2.4% in 2002 for the U.S. dollar.
Fair value of loans and debt
The fair value of fixed rate debt is determined for each loan by the discounting of future cash flows, based on the debenture
interest rate curves at the balance sheet date, after allowing for the spread corresponding to the group’s risk rating.
The net book value of outstanding bank loans and other floating rate loans is a reasonable approximation of their fair value.
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At 31st December 2002, the fair value of the debt amounts to € 2,671 million. At 31st December 2001, it amounted
to € 2,962.5 million.
Debts covered by collateral
There were no significant debts covered by collateral as at 31st December 2002 and 31st December 2001.
Confirmed credit lines
At 31st December 2002, L’Oréal and its subsidiaries have € 2,048 million of credit lines that are confirmed but not used
(€ 1,406 million at 31st December 2001).
NOTE 17 - DERIVATIVES AND EXPOSURE TO MARKET RISKS 
To manage its exposure to currency and interest rate risks arising in the course of its normal operations, the group uses
derivatives negotiated with organisations with the best credit ratings.
In accordance with the group’s rules, the currency and interest rate derivatives are set up exclusively for hedging purposes.
Hedging of currency risk
The group is exposed to currency risk from commercial transactions recorded on the balance sheet or from future transactions
considered to be highly probable.
The group’s policy on exposure to currency risk from its commercial transactions is to hedge at least 80% of the currency risk by
derivatives once the operating budgets have been allocated by the group’s subsidiaries. Currency risks stem mainly (about 85%)
from flows initiated inside the group.
All the group’s future currency flows are analysed in detailed forecasts for the coming budget year. Currency risks that emerge
are hedged by futures sales or purchases or by options, to reduce as far as possible the currency position of each subsidiary.
The duration of the derivatives is determined as appropriate for the group’s settlement flows.
As the group’s companies must borrow and invest their cash in their own currency, the exchange rate risks generated by
the management of their cash flow are almost non-existent.
With regard to the hedging methods, the group has set up a system of mutualised management of exchange rate risks which
involves clearing by the group’s bank, Regefi. The resulting net currency position of the group is hedged on the market.
Exchange rate derivatives are negotiated by Regefi or in exceptional cases directly by group subsidiaries if the currency is not
convertible, such operations being subject to control by Regefi.
The following derivatives are held for currency risk hedging purposes:
€ millions Nominal Market value
31.12.2002 31.12.2001 31.12.2002 31.12.2001
Currency futures
Purchase Euro / currency 1,196.9 1,161.9 84.2 7.6
EUR/USD 506.2 499.9 67.9 7.2
EUR/GBP 178.8 197.0 6.0 0.5
EUR/CHF 123.6 95.7 -0.5 0.1
EUR/CAD 64.5 45.0 5.7 0.9
EUR/West European currencies 89.0 98.6 -1.0 -0.8
EUR/East European currencies 128.0 56.7 0.6 -2.9
EUR/Asian currencies 32.2 79.0 2.0 4.5
EUR/Latin American currencies 12.6 31.6 1.7 -1.3
EUR/Other currencies 62.0 58.4 1.8 -0.6
Sale Euro / Asian currencies -32.2 -1.2 4.5 0.1
Purchase USD / currencies 311.6 266.7 2.4 13.6
USD/CAD 20.7 14.2 - 0.2
USD/Asian currencies 127.2 117.8 -0.7 4.0
USD/Latin American currencies 117.9 100.6 5.4 9.2
USD/Other currencies 45.8 34.1 -2.3 0.2
Sale USD / CHF -66.5 -90.3 4.8 -3.0
Other currency pairs 58.0 27.5 -1.7 0.4
Currency futures total 1,467.8 1,364.6 94.2 18.7
Currency options
EUR/USD 71.7 1.1
EUR/GBP 22.5 - 1.4 -
USD/CAD 16.2 11.7 0.2 0.3
USD/BRL 40.0 28.2 6.3 0.3
Other currency pairs 9.0 5.7 0.2 0.1
Currency options total 87.7 117.3 8.1 1.8
O/w call options total 97.3 132.6 10.6 2.0
O/w put options total -9.6 -15.3 -2.5 -0.2
Total 1,555.5 1,481.9 102.3 20.5
The put options total corresponds exclusively to the sale of previously purchased options when it appeared opportune to replace them with currency
futures.
The fair value of the derivatives is their market value.
Hedging of interest rate risk
The group mainly refinances at floating rates and uses interest rate derivatives to reduce net exposure to interest rate risk.
Such derivatives are never held for speculative reasons.
The derivatives are mainly swaps and interest rate options (purchase of caps) which are freely negotiated. 
The market values of the derivatives set out above should be compared with the market values of the debts that they hedge.
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The interest rate derivates are as follows :
€ millions Notional Market values
Interest rate derivatives 31.12.2002 31.12.2001 31.12.2002 31.12.2001
Borrowing floating interest-rate swaps
EUR Euribor / fixed rate 534.5 590.6 36.3 30.2
CAD Libcad / fixed rate - 37.6 - -1.4
Borrowing fixed interest-rate swaps
EUR Euribor / fixed rate 516.2 516.2 -4.5 1.7
USD Libor / fixed rate 238.3 472.0 - -1.6
CAD Libcad / fixed rate 32.3 -0.6
Floating/floating interest-rate swaps
EUR Euribor / Euribor 197.4 136.9 2.7 3.0
Purchases caps
EUR Euribor 952.4 1,064.1 1.7 1.3
USD Libor 762.6 508.1 0.1 0.6
CAD Libcad 12.1 39.1 - -
Total 3,245.8 3,364.6 35.7 33.8
The fair value of the interest rate derivatives is their market value. The market value of the interest rate derivatives is calculated by the discounting
of future flows at the interest rate ruling at the balance sheet date or applied by the third party banks.
Third party risk
The group has financial relations with international banks with the best credit ratings. The group thus considers that its exposure
to third party risk is low. 
Furthermore, the financial instruments used in exchange rate and interest rate risk management are issued by leading
international banking counterparties.
NOTE 18 - OFF-BALANCE SHEET CONTINGENT LIABILITIES
a) Lease commitments
These liabilities amount to € 1,310.8 million at 31st December 2002 compared with € 1,039.3 million at 31st December 2001,
of which:
• € 212.1 million is due in under one year at 31st December 2002 compared with € 192.9 million at 31st December 2001,
• € 579.1 million is due in 1 to 5 years at 31st December 2002 compared with € 529.3 million at 31st December 2001,
• and € 519.6 million is due in over 5 years at 31st December 2002 compared with € 317.1 million at 31st December 2001.
b) Other off-balance sheet contingent liabilities 
The confirmed credit lines are indicated in note 16.
The other off-balance sheet contingent liabilities are as follows:
€ millions 31.12.2002 31.12.2001
Commitments given(1) 58.2 70.0
Minorities buyback commitments 155.0 164.9
Documentary credits 3.6 2.6
Commitments received 27.6 21.8
(1) These consist mainly of commitments given to administrations or commitments concerning loans granted to third parties who are partners of the group.
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c) Shareholders’ agreement entered into by L’Oréal
L’Oréal and the Elf-Aquitaine group (a subsidiary of the TotalFinaElf group) have concluded a shareholders’ agreement 
concerning their respective interests in Sanofi-Synthélabo and governing their concerted action in relation to this company.
The agreement, drawn up in anticipation of the merger of Sanofi and Synthélabo that became effective on 18th March 1999,
will remain in force until 2nd December 2004. Unless one of the parties gives notice of termination one year before the latter
date, the agreement will then be renewed indefinitely by tacit agreement, but may then be terminated at any time subject 
to one year’s prior notice.
The agreement stipulates that the two parties will consult with one another before all annual general meetings and Board 
meetings, and before any important decision resulting in a commitment for Sanofi-Synthélabo. Furthermore, if a transaction
could mean that either party could lose the possibility of accounting for its interest in Sanofi-Synthélabo by the equity method,
the transaction is subject to the prior approval of both partners.
L’Oréal and the Elf-Aquitaine group have agreed to retain 19.4% of the current share capital of Sanofi-Synthélabo until the
expiry of the agreement (except that each of the two groups is allowed to sell 0.5% of the share capital of Sanofi-Synthélabo
per rolling period of 12 consecutive months: in this case, the other group is granted a pre-emption right for the shares concerned).
At 31st December 2002, the two groups held 19.5% and 24.8% of the share capital respectively, which means that the 
Elf-Aquitaine group is free to sell a 5.4% stake, which would make its interest almost the same as that of L’Oréal. 
If Elf-Aquitaine wishes to sell its "free" shares, it cannot do so to a competitor of L’Oréal or of Sanofi-Synthélabo.
d) Possible liabilities
In its normal operations, the group is involved in legal actions and is subject to tax assessments, customs controls and
administrative controls. The group sets aside a provision wherever a risk is found to exist, and an estimate of its cost is possible.
At present there is no exceptional event or dispute which could materially and with serious probability affect the results, financial
situation, assets or operations of the L’Oréal company and group.
e) Environmental risks
The group carefully monitors changes in regulations and laws relating to environmental protection, and does not expect that
they will have a significant impact on the future operations, financial situation, results or assets of the group.
NOTE 19 - NET SALES
Net sales represent sales to third parties by L’Oréal and its French and foreign subsidiaries.
In 2002 net sales totalled € 14,288 million, compared with € 13,740.4 million in 2001.
The breakdown of net sales by branch and geographic zone is indicated in the "Sectorial Information" section of the notes.
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Breakdown of sales - France/Rest of the World
2002 2001
€ millions as % € millions as %
France 2,019.9 14.1 1,928.8 14.0
Rest of the World 12,268.1 85.9 11,811.6 86.0
Group 14,288.0 100.0 13,740.4 100.0
NOTE 20 - PERSONNEL COSTS AND NUMBER OF EMPLOYEES
Personnel costs include amounts paid as employee profit sharing and the actuarial charge relating to the recording of
employee retirement obligation and related benefits.
The total number of employees was 50,491 at 31st December 2002, compared with 49,150 at 31st December 2001.
Number of employees(1) 31.12.2002 31.12.2001
Western Europe 24,755 24,316
North America 10,021 10,035
Rest of the World 15,715 14,799
Total 50,491 49,150
(1) Including companies consolidated by the proportional method.
Remuneration of directors and management
€ millions 2002 2001
Boards of Directors 0.7 0.7
Management structures(1) 15.7 13.7
(1) Remuneration paid by all group companies.
Remuneration of senior managers
The gross total remuneration paid to the Chairman and Chief Executive Officer for 2002 amounted to € 6,264,634, including
benefits and directors’ fees, of which the fixed part amounted to € 3,048,980.
The gross total remuneration paid to the Executif Vice-President, Administration and Finance, for 2002 amounted to
€ 1,722,776, including benefits and directors’ fees, of which the fixed part amounted to € 961,252.
NOTE 21 - RESEARCH AND DEVELOPMENT EXPENDITURE
This expenditure amounted to € 468 million in 2002, compared with € 432 million in 2001.
NOTE 22 - CHARGES TO PROVISIONS 
This item amounted to -€ 51.2 million in 2002 compared with -€ 29.9 million in 2001. It consisted mainly of current assets 
in an amount of -€ 2.4 million (-€ 24.6 million in 2001), and liabilities and charges in an amount of -€ 48.8 million
(-€ 5.1 million in 2001).
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NOTE 23 - FINANCIAL EXPENSE - NET (EXCLUDING EXCHANGE RATE GAINS AND LOSSES) 
€ millions 2002 2001
Net interest expense -69.9 -126.2
Net gain on disposals of short-term investments 8.0 2.9
Payment discounts -56.9 -51.1
Other 1.3 2.7
Net charges to financial provisions -24.7 4.4
Financial expenses - net -142.2 -167.3
The exchange rate effect is included in the adjusted operating profit. 
NOTE 24 - INCOME TAX 
a) Detailed breakdown of corporate income tax 
€ millions 2002 2001 
Tax due
- operating profit 625.4 562.8
- non-operational items -17.2 8.1
Deferred tax
- operating profit -45.6 -26.9
- non-operational items -49.3 7.7
Income tax 513.3 551.7
Of which:
- impact of tax rate differences on restructuring costs -15.0 0.4
- impact of tax rate differences on capital gains and losses on fixed assets -7.4 15.4
- impact of tax rate differences on treasury shares -44.1 -
b) Analysis of tax charge
The difference between the theoretical tax charge, calculated on the basis of the tax rate of the parent company, and the effective
tax charge for the group in 2002 may be analysed as follows:
€ millions 2002 2001
Net book profit before tax 1,453.2 1,538.3
Parent company tax rate 35.43% 36.43%
Theoritical tax on net book profit 514.9 560.4
Impact of permanent differences 109.3 47.5
Impact of tax rate differences -77.2 -79.6
Change in non-recorded deferred taxes -13.9 16.8
Other(1) -19.8 6.6
Group tax charge 513.3 551.7
(1) Including tax credits, tax reassessments and provisions for tax liabilities.
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c) Deferred taxes in the balance sheet
The net change in deferred taxes (assets and liabilities) may be analysed as follows:  
€ millions
Balance of deferred tax assets at 31st December 2000(1) 397.6
Balance of deferred tax liabilities at 31st December 2000 -82.0
Profit effect 19.2
Exchange effect -5.3
Other effects 7.7
Balance of deferred tax assets at 31st December 2001 425.9
Balance of deferred tax liabilities at 31st December 2001 -88.7
Profit effect 94.9
Exchange effect -4.3
Other effects 6.4
Balance of deferred tax assets at 31st December 2002 479.2
Balance of deferred tax liabilities at 31st December 2002 -45.0
(1) Of which € 242.4 million resulting from the application of the new employee retirement obligation calculation method.
Deferred tax assets and liabilities recorded in the balance sheet may be divided into the following categories:
€ millions 31.12.2002 31.12.2001
Deferred Deferred Deferred Deferred
tax tax tax tax
assets liabilities assets liabilities
Temporary differences 473.2 45.0 414.6 88.7
Tax credits and tax loss carry-forwards 6.0 11.3 -
Deferred tax total 479.2 45.0 425.9 88.7
Deferred tax assets whose recovery is not considered probable are not recorded in the financial statements; such assets totalled € 72.7 million at 
31st December 2002, compared with € 105.4 million at 31st December 2001.
NOTE 25 - GROUP’S SHARE OF NET PROFIT BEFORE CAPITAL GAINS AND
LOSSES OF EQUITY AFFILIATES 
This item states the net profit before capital gains and losses and minority interests of equity affiliates, as defined in the
Accounting principles.
NOTE 26 - CAPITAL GAINS AND LOSSES ON THE DISPOSAL OF FIXED ASSETS NET OF TAX
This item amounted to -€ 16.6 million in 2002, compared with € 130.7 million in 2001.  
In 2002, this item consisted mainly of the disposal or exceptional amortisation of non-strategic fixed assets in individual
amounts that are not material.
In 2001, this item consisted mainly of the profit from the sale of all holdings in the Marie Claire group, which took place
in March 2001, and the impact of the disposal of Lanvin S.A. and its subsidiaries. The capital gain net of tax from these two
transactions amounted to € 110.2 million.
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NOTE 27 - RESTRUCTURING COSTS 
These costs were accounted for mainly by provisions and costs relating to industrial and commercial reorganisation of existing
companies, and of companies acquired during the year.
The item amounted to -€ 31.5 million in 2002, compared with -€ 28.3 million in 2001.
NOTE 28 - AMORTISATION OF GOODWILL
Amortisation of goodwill amounted to -€ 50.3 million in 2002, compared with -€ 40.7 million in 2001, and is set out in note 4,
"Goodwill".
NOTE 29 - NET PROFIT BEFORE CAPITAL GAINS AND LOSSES AND AFTER MINORITY
INTERESTS PER SHARE (€)
Net profit before capital gains and losses and after minority interests per share is based on the weighted average number of
shares outstanding, after deducting the average number of shares held by consolidated companies which are not included in
shareholders’ equity. Treasury shares held for stock option plans and entered under Short-term investments are not deducted
in this calculation.
The table below indicates earnings per share for the two years presented:
31.12.2002
Earnings Number Earnings
(€ millions) of shares per share (€)
Net profit before capital gains and losses and after minority interests 1,456.2 675,990,516 2.15
At 31st December 2002, there are no items which have a dilutive effect on the number of shares outstanding. The 1,640,000
L’Oréal shares held by the consolidated companies are included in the calculation of earnings per share.
31.12.2001
Earnings Number Earnings
(€ millions) of shares per share (€)
Net profit before capital gains and losses and after minority interests 1,229.1 676,062,160 1.82
At 31st December 2001, there were no items which have a dilutive effect on the number of shares outstanding. No L’Oréal shares
held by the consolidated companies are included in the calculation of earnings per share.
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NOTE 30 - VARIATION IN WORKING CAPITAL REQUIREMENT 
In 2002 and in 2001, this item amounted to € 162.8 million and € 139.2 million respectively, and may be analysed as follows:  
€ millions 2002 2001
Stocks -67.3 52.4
Creditors -288.8 -245.5
Debts 518.9 332.2
NOTE 31 - VARIATION IN OTHER FINANCIAL ASSETS 
This line includes flows relating to treasury shares during the accounting period, classified as short-term investments and as
deductions from shareholders’ equity.
NOTE 32 - IMPACT OF CHANGES IN THE SCOPE OF CONSOLIDATION
In 2002, this item mainly relates to the acquisition of Artec Inc.
In 2001, this item mainly related to the disposal of Marie Claire and Lanvin and the acquisitions of Biomedic, Colorama and
Shu Uemura.
NOTE 33 - CASH AND CASH EQUIVALENTS AT END OF YEAR
This item amounted to € 529.3 million at 31st December 2002 and € 594.1 million at 31st December 2001, and may be analysed
as follows: 
€ millions 31.12.2002 31.12.2001
Short-term investments excluding treasury shares 160.5 142.7
Cash and short-term funds excluding accrued interest 534.4 541.6
Overdrafts, etc. -165.6 -90.2
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CONSOLIDATED COMPANIES
A - COMPANIES CONSOLIDATED BY THE FULL CONSOLIDATION METHOD (1)
Companies Head Office N° Siren % Holding % Control(2)
Anglo Overseas Finance (India) Private Ltd India 99.99
Areca & Cie France 784 787 517 100.00
Avenamite S.A. Spain 100.00
Beautycos International Co Ltd China 100.00
Belcos Japan 100.00
Belocap Productos Capilares Ltda Brazil 99.99
Biotherm Monaco 56 S 00206 99.70
Biotherm Distribution & Cie France 552 127 458 100.00
Caribel Fragrances Inc. Puerto Rico 100.00
Carson Midrand Manufacturing (Pty) Ltd South Africa 100.00
Carson Products West Africa Ltd Ghana 100.00
Centre logistique d’Essigny France 443 660 618 100.00
Centrex France 728 201 898 100.00
Chimex France 548 201 490 100.00
Cobelsa Cosmeticos S.A. Spain 100.00
Colainaf Morocco 100.00
Consortium Général de Publicité France 552 089 690 100.00
Cosbel SA de CV Mexico 100.00
Cosmelor Japan 100.00
Cosmephil Holdings Corporation Philippines 100.00
Cosmetica Activa Portugal Ltda Portugal 100.00
Cosmétil Morocco 49.80 100.00
Cosmétique Active Belgilux Belgium 100.00
Cosmétique Active Deutschland Germany 100.00
Cosmétique Active España Spain 100.00
Cosmétique Active France France 325 202 711 99.99
Cosmétique Active International France 350 760 559 100.00
Cosmétique Active Ireland Ireland 100.00
Cosmétique Active Italia Italy 100.00
Cosmétique Active Nederland Netherlands 100.00
Cosmétique Active Osterreich GmbH Austria 100.00
Cosmétique Active Suisse Switzerland 99.40
Cosmétique France AB Sweden 100.00
Cospar S.A. France 742 005 200 100.00
Dr Pfalz Germany 100.00
Elebelle (Pty) Ltd South Africa 100.00
Episkin France 412 127 565 100.00
Erwiton S.A. Uruguay 100.00
Exclusive Signatures International (UK) Ltd United Kingdom 100.00
Exclusive Signatures International France 433 976 255 100.00
Fapagau et Cie France 318 247 285 100.00
Faprogi France 393 461 454 100.00
Finval France 341 643 781 100.00
Frabel Mexico 100.00
France Beauté Aktiebolag Sweden 100.00
French Cosmetics UK Ltd United Kingdom 100.00
Garnier New Zealand Ltd New Zealand 100.00
(1) In accordance with the requirements of article D248-12 of French company law, it is hereby stated that some of the information provided above is incomplete.
(2) Equivalent to the percentage holding except where otherwise indicated.
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Companies Head Office N° Siren % Holding % Control(2)
Gemey Paris – Maybelline New York France 339 381 584 100.00
Geral Inc. United States 100.00
Goldys International France 337 844 914 100.00
Helena Rubinstein France 542 033 485 100.00
Helena Rubinstein Italia Spa Italy 100.00
Holdial France 324 084 698 100.00
Kosmepol Sp Z.O.O. Poland 100.00
L & J Re France 413 178 740 100.00
Laboratoire Garnier & Cie France 572 186 047 100.00
Laboratoires Garnier Paris France 339 419 962 100.00
Lai Mei Cosmetics International Trading Cy Ltd China 100.00
Lancarome A/S Denmark 100.00
Lancôme Institut et Cie France 332 111 848 100.00
Lancôme Parfums & Beauté & Cie France 302 387 196 100.00
Lancos Japan 100.00
La Roche-Posay Dermato-Cosmétique France 410 336 127 99.96
La Roche-Posay Laboratoire Pharmaceutique France 306 688 714 99.96
Lascad France 319 472 775 100.00
Lavicosmetica Cosmétique Active Hellas Greece 51.00
Lehoux et Jacque France 572 072 544 100.00
L.I.D.V. France 975 620 675 100.00
L’Oréal Argentina S.A.I.C. Argentina 100.00
L’Oréal Australia Australia 100.00
L'Oréal Belgilux Belgium 99.99
L’Oréal Canada Inc. Canada 100.00
L’Oréal Ceska Republica S.R.O. Czech Republic 100.00
L’Oréal Chile S.A. Chile 100.00
L’Oréal (China) Co. Ltd China 100.00
L’Oréal Colombia S.A. Colombia 100.00
L’Oréal Danmark A/S Denmark 100.00
L'Oréal Deutschland GmbH Germany 100.00
L’Oréal Division Productos de Lujo S.A. Spain 100.00
L’Oréal Division Productos Gran Publico S.A. Spain 100.00
L’Oréal Division Productos Profesionales S.A. Spain 100.00
L’Oréal España S.A. Spain 100.00
L’Oréal Finland Oy Finland 100.00
L’Oréal Guatemala Guatemala 100.00
L’Oréal Hellas S.A. Greece 100.00
L’Oréal Hong-Kong Limited Hong-Kong 100.00
L’Oréal H.U.P. GmbH & Co Kg Germany 100.00
L’Oréal H.U.P. Beteiligungs GmbH Germany 100.00
L’Oréal India Ltd India 100.00
L’Oréal Indonesia Indonesia 100.00
L’Oréal Investments BV Netherlands 100.00
L’Oréal Israel Ltd Israel 92.97
L’Oréal Italia Spa Italy 100.00
L’Oréal Japan Ltd Japan 100.00
L’Oréal Korea South Korea 100.00
L’Oréal Latvia Latvia 100.00
L’Oréal Liban Lebanon 75.17
L’Oréal Libramont Belgium 99.99
L’Oréal Luxury Products Division Australia Australia 100.00
L’Oréal Luxury Products Norge Norway 100.00
(2) Equivalent to the percentage holding except where otherwise indicated.
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Companies Head Office N° Siren % Holding % Control(2)
L’Oréal Magyarorszag Kozmetikai Kft Hungary 100.00
L’Oréal Malaysia Malaysia 97.50
L’Oréal Maroc Morocco 50.00 100.00
L’Oréal Mexico SA de CV Mexico 100.00
L’Oréal Mexico Servicios SA de CV Mexico 100.00
L’Oréal Middle East Fze United Arab Emirates 100.00
L’Oréal Nederland BV Netherlands 100.00
L’Oréal New Zealand New Zealand 100.00
L’Oréal Norge A/S Norway 100.00
L’Oréal Österreich GmbH Austria 100.00
L'Oréal Perú S.A. Peru 100.00
L’Oréal Philippines Philippines 100.00
L’Oréal Polska Sp Z.O.O. Poland 100.00
L’Oréal Portugal Portugal 100.00
L’Oréal Produits de Luxe France France 314 428 186 100.00
L’Oréal Produits de Luxe International France 309 064 947 100.00
L'Oréal Produktion Deutschland Beteiligung GmbH Germany 100.00
L'Oréal Produktion Deutschland GmbH & Co Kg Germany 100.00
L’Oréal Romania Romania 100.00
L’Oréal Saipo Industriale Spa Italy 100.00
L’Oréal Saipo Spa Italy 100.00
L’Oréal Services Centre de Coordination S.A. Belgium 99.99
L'Oréal Singapore Pte Ltd Singapore 100.00
L’Oréal Slovenija Kozmetika D.O.O. Slovenia 100.00
L’Oréal Slovensko S.R.O. Slovakia 100.00
L’Oréal South Africa Holdings Ltd South Africa 100.00
L’Oréal Suisse S.A. Switzerland 100.00
L'Oréal Sverige AB Sweden 100.00
L'Oréal Taiwan Co. Ltd Taiwan 100.00
L’Oréal Thailand Ltd Thailand 100.00
L’Oréal Turkiye Turkey 100.00
L'Oréal UK Ltd United Kingdom 100.00
L’Oréal Uruguay S.A. Uruguay 100.00
L’Oréal USA Inc. United States 100.00
L’Oréal Venezuela CA Venezuela 100.00
L’Oréal Zagreb Croatia 100.00
Marigny Manufacturing Australia Pty Ltd Australia 100.00
Maybelline Kk Japan 100.00
Maybelline Suzhou Cosmetics Ltd China 100.00
Naderman France 409 791 498 100.00
Nihon L'Oréal Kk Japan 100.00 
Ormes Bel Air France 329 744 809 100.00
Parbel of Florida Inc. United States 100.00
Par-Bleue France 394 015 812 100.00
Parcofrance Kosmetika Handelsgesellschaft Austria 100.00
Parfums & Beauté Belgilux Belgium 100.00
Parfums & Beauté Deutschland Gmbh Germany 100.00
Parfums & Beauté Hellas Greece 100.00
Parfums & Beauté Italia Italy 100.00
Parfums & Beauté Malaysia Malaysia 98.77
Parfums & Beauté Nederland BV Netherlands 100.00
Parfums & Beauté Suisse S.A. Switzerland 99.63
Parfums Cacharel et Cie France 321 422 172 100.00
Parfums Guy Laroche France 304 504 574 100.00
(2) Equivalent to the percentage holding except where otherwise indicated.
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Companies Head Office N° Siren % Holding % Control(2)
Parfums Paloma Picasso & Cie France 333 006 252 100.00
Parfums Ralph Lauren France 334 121 415 100.00
Parlanvin France 381 480 060 100.00
Parmobel Limited United Arab Emirates 75.00
Prestige & Collections International France 334 171 113 100.00
Procosa - Productos de Beleza S.A. Brazil 100.00
Productora Albesa S.A. Spain 100.00
Productos Capilares L'Oréal S.A. Spain 100.00
Productos de Cosmetica Selectiva Lda Portugal 100.00
Redken France France 441 459 443 100.00
Redken Laboratories GmbH Germany 100.00
Regefi France 592 065 239 100.00
Rusbel Russian Federation 100.00
Scental Hong-Kong 100.00
Selective Beauté International et Cie France 333 314 722 100.00
Shu Uemura Cosmetic Corporate Taiwan 75.00
Siampar Limited Thailand 100.00
Sicos et Cie France 687 020 214 100.00
Sincos Pte Ltd Singapore 100.00
Socex de Expansao Mercantil em Cosmeticos Brazil 99.00
Société Civile Immobilière Socinay France 100.00
Société de Développement Artistique France 417 893 112 100.00
Sofamo Monaco 58 S 00670 99.96
Sofy France 305 949 034 100.00
Soprocos France 586 680 092 100.00
Soprogem France 382 460 392 100.00
Soproréal France 383 069 663 100.00
Sparlys France 652 054 065 100.00
Swan Beauties Pvt Ltd India 100.00
Thai Shu Uemura Thailand 68.15
Venprobel Venezuela 100.00
Yasulor Indonesia Indonesia 100.00
(2) Equivalent to the percentage holding except where otherwise indicated.
B - COMPANIES CONSOLIDATED BY THE PROPORTIONAL CONSOLIDATION METHOD
Companies Head Office N° Siren % Holding % Control(5)
Beauté-Créateurs France 475 682 068 50.00 (3)
Cosimar Japon KK Japan 50.00 (3)
Galderma Alpha France 440 139 772 50.00 (4)
Galderma Argentina S.A. Argentina 50.00 (4)
Galderma Australia Pty Ltd Australia 50.00 (4)
Galderma Belgilux N.V. Belgium 50.00 (4)
Galderma Brazil Limitada Brazil 50.00 (4)
Galderma Canada Inc. Canada 50.00 (4)
Galderma Colombia S.A. Colombia 50.00 (4)
Galderma Hellas Greece 50.00 (4)
Galderma Hong-Kong Hong-Kong 50.00 (4)
Galderma India Private Ltd India 50.00 (4)
Galderma Italia SPA Italy 50.00 (4)
Galderma Korea Ltd South Korea 50.00 (4)
Galderma KK Japan 50.00 (4)
Galderma Laboratories Inc. United States 49.05 (4) 50.00
Galderma Laboratorium GmbH Germany 50.00 (4)
(3) Companies owned jointly with Les Trois Suisses.
(4) Companies owned jointly with Nestlé.
(5) Equivalent to the percentage holding except where otherwise indicated.
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Companies Head Office N° Siren % Holding % Control(5)
Galderma Laboratories South Africa Pty Ltd South Africa 50.00 (4)
Galderma Mexico SA de CV Mexico 50.00 (4)
Galderma Nordic AB Sweden 50.00 (4)
Galderma Omega France 440 139 533 50.00 (4)
Galderma Perú Laboratorios Peru 50.00 (4)
Galderma Pharma S.A. Switzerland 50.00 (4)
Galderma Philippines Inc. Philippines 50.00 (4)
Galderma Polska Poland 50.00 (4)
Galderma Production Canada Inc. Canada 50.00 (4)
Galderma Research & Development France 317 099 679 50.00 (4)
Galderma Research And Development Inc. United States 50.00 (4)
Galderma S.A. Switzerland 50.00 (4)
Galderma Singapore Singapore 50.00 (4)
Galderma UK Ltd United Kingdom 50.00 (4)
Galderma Uruguay Uruguay 50.00 (4)
Innéov Belgique Belgium 50.00 (4)
Innéov Deutschland GmbH Germany 50.00 (4)
Innéov España S.A. Spain 50.00 (4)
Innéov France France 444 491 161 50.00 (4)
Innéov Portugal Portugal 50.00 (4)
Laboratorios Galderma S.A. Spain 50.00 (4)
Laboratoires Galderma S.A. France 325 186 617 50.00 (4)
Laboratorios Galderma Chile Limitada Chile 50.00 (4)
Laboratorios Galderma Venezuela S.A. Venezuela 50.00 (4)
Laboratorios Innéov France 443 051 784 50.00 (4)
Le Club des Créateurs de Beauté Belgium 50.00 (3)
Le Club des Créateurs de Beauté Taiwan Taiwan 50.00 (3)
Le Club des Créateurs de Beauté UK United Kingdom 50.00 (3)
Le Club des Créateurs de Beauté USA United States 50.00 (3)
Le Club des Créateurs Cosmetic Versand Verwaltungs GmbH Germany 50.00 (3)
Le Club des Créateurs Cosmetic Versand GmbH and Co Kg Germany 50.00 (3)
Shu Uemura Cosmetics Inc. Japan 35.00
(3) Companies owned jointly with Les Trois Suisses.
(4) Companies owned jointly with Nestlé.
(5) Equivalent to the percentage holding except where otherwise indicated.
C - COMPANIES CONSOLIDATED BY THE EQUITY METHOD
Companies Head Office N° Siren % Holding % Control(6)
Club des Créateurs de Beauté KK Japan 20.00
Nobara Inc. United States 35.00
Sanofi-Synthélabo France 395 030 844 19.98 27.54
Shu Uemura International Hong-Kong 22.75
(6) Equivalent to the percentage holding except where otherwise indicated.
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STATUTORY AUDITORS’ REPORT 
CONSOLIDATED FINANCIAL STATEMENTS
Year ended 31st December 2002
In compliance with the assignment entrusted to us by your Annual General Meeting, we have audited the accompanying
consolidated financial statements of L’Oréal for the year ended 31st December 2002.
The consolidated financial statements have been approved by the Board of Directors. Our role is to express an opinion
on these financial statements, based on our audit.
We conducted our audit in accordance with professional standards applicable in France. Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free
of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures
in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides
a reasonable basis for our opinion.
In our opinion, the consolidated financial statements give a true and fair view of the financial position and the assets and
liabilities of the group as at 31st December 2002 and the results of its operations for the year then ended in accordance
with rules and accounting principles generally accepted in France. 
We have also performed the procedures required by law on the group financial information given in the report of the Board
of Directors. We have no comment to make as to the fair presentation of this information nor its consistency with the conso-
lidated financial statements.
Paris-la-Défense and Neuilly, 26th March 2003
The statutory Auditors
Pierre Coll Etienne Jacquemin
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